For the quarter ending 2025-03-31, HOOK made $24,329K in revenue. -$16,781K in net income. Net profit margin of -68.98%.
| Income Statement | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|
| Restructuring | 133 | 866 | 878 | 54 |
| Impairment | - | 1,277 | 172 | - |
| Research and development | 12,859 | 16,597 | 15,565 | 19,749 |
| General and administrative | 6,886 | 4,775 | 6,732 | 3,945 |
| Total operating expenses | 19,878 | 24,153 | 23,347 | 23,748 |
| Revenue from collaboration and licensing | 2,004 | 18,977 | 4,703 | 1,290 |
| (loss) income from operations | -17,874 | -5,176 | -18,644 | -22,458 |
| Other income (expense), net | 1,984 | -2,421 | 1,811 | -218 |
| Interest expense | - | 1 | - | - |
| Interest income | 236 | 910 | 809 | 1,073 |
| Grant income | 227 | 1,353 | 2,183 | 2,508 |
| Total other income, net | 2,447 | -160 | 4,803 | 3,363 |
| Net (loss) income before tax | -15,427 | -5,336 | -13,841 | -19,095 |
| Income tax expense | - | -26 | - | - |
| Net (loss) income | -15,427 | -5,283 | -13,841 | -19,095 |
| Foreign currency translation (loss) gain, net of tax | -1,354 | 2,014 | -1,360 | 178 |
| Comprehensive (loss) income | -16,781 | -3,269 | -15,201 | -18,917 |
| Basic eps | -1.23 | -0.425 | -1.1 | -1.52 |
| Diluted eps | -1.23 | -0.425 | -1.1 | -1.52 |
| Basic average shares | 12,544,777 | -6,269,377 | 12,538,774 | 12,538,774 |
| Diluted average shares | 12,544,777 | -6,269,377 | 12,538,774 | 12,538,774 |
HOOKIPA Pharma Inc. (HOOK)
HOOKIPA Pharma Inc. (HOOK)